Pinnacle Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,165
| Closed | -$236K | – | 166 |
|
|
2019
Q2 | $236K | Buy |
2,165
+135
| +7% | +$14.7K | 0.02% | 155 |
|
|
2019
Q1 | $227K | Buy |
+2,030
| New | +$227K | 0.02% | 153 |
|
|
2018
Q2 | – | Sell |
-4,300
| Closed | -$459K | – | 164 |
|
|
2018
Q1 | $459K | Sell |
4,300
-6,680
| -61% | -$713K | 0.03% | 124 |
|
|
2017
Q4 | $1.17M | Buy |
10,980
+1,209
| +12% | +$129K | 0.07% | 73 |
|
|
2017
Q3 | $1.09M | Buy |
9,771
+240
| +3% | +$26.7K | 0.07% | 69 |
|
|
2017
Q2 | $985K | Buy |
9,531
+195
| +2% | +$20.2K | 0.06% | 75 |
|
|
2017
Q1 | $913K | Buy |
9,336
+1,326
| +17% | +$130K | 0.06% | 75 |
|
|
2016
Q4 | $709K | Buy |
8,010
+750
| +10% | +$66.4K | 0.05% | 85 |
|
|
2016
Q3 | $653K | Buy |
+7,260
| New | +$653K | 0.05% | 58 |
|